Breaking News Instant updates and real-time market news.

SGYP

Synergy Pharmaceuticals

$1.60

(0.00%)

, ESRX

Express Scripts

$76.84

-0.675 (-0.87%)

09:11
08/07/18
08/07
09:11
08/07/18
09:11

Express Scripts adds Synergy Pharmaceuticals' Trulance to formulary list

Synergy Pharmaceuticals (SGYP) announced that Express Scripts (ESRX) will add Trulance to its National Preferred Formulary List, effective January 1, 2019. This follows the FDA approval of the second indication for Trulance for the treatment of adults with irritable bowel syndrome with constipation, or IBS-C, in January 2018. Trulance was first approved by the FDA for the treatment of adults with chronic idiopathic constipation, or CIC in January 2017. Trulance is the only prescription medication for adults with CIC and IBS-C that can be taken once-daily, with or without food, at any time of the day.

SGYP

Synergy Pharmaceuticals

$1.60

(0.00%)

ESRX

Express Scripts

$76.84

-0.675 (-0.87%)

  • 24

    Aug

SGYP Synergy Pharmaceuticals
$1.60

(0.00%)

11/14/17
BTIG
11/14/17
NO CHANGE
Target $7
BTIG
Buy
Synergy Pharmaceuticals price target lowered to $7 from $11 at BTIG
BTIG analyst Timothy Chiang lowered his price target on Synergy Pharmaceuticals to $7, saying the revision reflects the potential risk of need for additional equity funding by late 2018/early 2019. Chiang notes that the company may be able to access $100M early next year as part of its loan agreement with CRG LP, but it must meet market cap and Trulance sales minimum requirements. The analyst keeps his Buy rating on Synergy Pharmaceuticals, saying the company is in position to benefit from increased payer access for Trulance in 2018 and the potential for an expanded treatment indication for IBS-C.
01/05/18
OPCO
01/05/18
DOWNGRADE
OPCO
Perform
Synergy Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
Oppenheimer analyst Derek Archila downgraded Synergy Pharmaceuticals to Perform citing the "nagging capital overhang." The analyst sees the potential for additional dilutive financing in 2018 saying the company may not be able to qualify for the third and fourth tranches of funding from the CRG deal. Any additional equity offerings may require a meaningful discount to the current stock price, Archila tells investors in a research note.
01/25/18
WELS
01/25/18
NO CHANGE
WELS
Outperform
Ironwood outlook unchanged after Trulance approval, says Wells Fargo
Wells Fargo analyst David Maris said that Synergy Pharmaceuticals (SGYP) received FDA approval for Trulance for the treatment of irritable bowel syndrome with constipation, to add to the drug's existing approval for chronic idiopathic constipation. Ironwood's (IRWD) Linzess was initially approved in 2012 for both IBS-C and CIC, noted Maris, who said he expected Trulance's approval in IBS-C and is not making any changes to his Ironwood model following the news. He believes Trulance was already being used off label in IBS-C to some degree, but will be watching if the new on-label indication impacts market share, he said. Maris keeps an Outperform rating on Ironwood shares.
01/25/18
BTIG
01/25/18
NO CHANGE
Target $7
BTIG
Buy
Synergy funding worries may be overdone, says BTIG
BTIG analyst Timothy Chiang noted that Synergy Pharmaceuticals (SGYP) announced that Trulance received expanded FDA approval for IBS-C, which puts it more on par with market leader Linzess from Ironwood (IRWD) and Allergan (AGN). He sees Trulance benefiting from increased payor access and believes the company will have sufficient cash in order to gain access to a second loan tranche of $100M expected by next month, stating that funding worries may be overdone. Chiang keeps a Buy rating and $7 price target on Synergy shares.
ESRX Express Scripts
$76.84

-0.675 (-0.87%)

08/02/18
SBSH
08/02/18
NO CHANGE
SBSH
Vote against Express Scripts deal 'somewhat shortsighted,' says Citi
Citi analyst Ralph Giacobbe believes a vote against Cigna's (CI) proposed acquisition of Express Scripts (ESRX), which the Wall Street Journal reported that activist Carl Icahn will push for, could prove "somewhat shortsighted given the changing and evolving healthcare landscape and the integrated offering and cash flow that a combined entity would generate to compete more effectively." The analyst says that regardless of the outcome, he remains positive on Cigna shares. The company's model should continue to drive growth without Express Scripts, and potentially enhance growth with the deal, Giacobbe tells investors in a research note. He keeps a Buy rating on Cigna.
08/02/18
JPMS
08/02/18
NO CHANGE
JPMS
Overweight
Cigna holders unlikely to vote down Express Scripts deal, says JPMorgan
While Cigna (CI) shares have underperformed peers since the deal for Express Scripts (ESRX) was announced in March, shareholders are unlikely to vote down the transaction, JPMorgan analyst Gary Taylor tells investors in a research note after the Wall Street Journal reported that Carl Icahn has built a stake and will push for voting against the deal. The analyst admits the market is taking a more negative view, as Express Scripts' 16% spread to offer value widened to 25% yesterday. Taylor believes few shareholders have questioned the strategic rational of the merger. He believes, however, that some of Icahn's points could resonate with bears in the near-term. The analyst keeps an Overweight rating on Cigna.
08/03/18
RHCO
08/03/18
NO CHANGE
Target $244
RHCO
Buy
Cigna price target raised to $244 from $220 at SunTrust
SunTrust analyst David MacDonald raised his price target on Cigna (CI) to $244 and kept his Buy rating after its "strong" Q2 results showed a "sizable" earnings beat across its business lines and lower expected medical cost trends. The analyst also maintains his bullish view on the pending Express Scripts (ESRX) deal, stating that the potential benefits of the combination are underappreciated give the strong momentum of the latter heading into 2019. MacDonald contends that investors' merger related concerns are "misplaced" and also sees Cigna valuation as "compelling".
08/07/18
LEHM
08/07/18
NO CHANGE
LEHM
Overweight
Cigna shares have upside with deal or no deal, says Barclays
Barclays analyst Steve Valiquette sees upside in shares of Cigna (CI) no matter the outcome of the shareholder vote on August 24 relating to its proposed acquisition of Express Scripts (ESRX). Under a deal break scenario, Cigna should trade at a multiple relatively in-line to diversified peer Anthem (ANTM), implying a fair value of $215, Valiquette tells investors in a research note. If the deal is approved, the analyst sees Cigna shares falling to $180 in the near term. However, his sum-of-the-parts analysis yields a current fair value of $213 per share. As such, the analyst sees upside potential on Cigna in both merger vote scenarios. Valiquette keeps an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$1,883.50

8.05 (0.43%)

19:36
08/21/18
08/21
19:36
08/21/18
19:36
Hot Stocks
Amazon.com's AWS announces availability of T3 instances for EC2 »

Amazon Web Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Sep

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$286.28

0.6 (0.21%)

19:28
08/21/18
08/21
19:28
08/21/18
19:28
General news
Breaking General news story on S&P 500, SPDR S&P 500 ETF Trust »

Aide for House Speaker…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$286.28

0.6 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$172.65

0.15 (0.09%)

, FEYE

FireEye

$14.57

0.135 (0.94%)

19:21
08/21/18
08/21
19:21
08/21/18
19:21
Hot Stocks
Facebook removed multiple pages, groups, accounts over 'inauthentic' behavior »

Facebook (FB) said in a…

FB

Facebook

$172.65

0.15 (0.09%)

FEYE

FireEye

$14.57

0.135 (0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 06

    Sep

  • 06

    Sep

  • 12

    Sep

  • 18

    Sep

  • 10

    Oct

  • 28

    Oct

SE

Sea Limited

$14.31

0.47 (3.40%)

19:06
08/21/18
08/21
19:06
08/21/18
19:06
Earnings
Sea Limited reports Q2 adjusted EBITDA ($161.9M) vs. ($50.9M) last year »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

URBN

Urban Outfitters

$47.75

0.23 (0.48%)

, LZB

La-Z-Boy

$33.03

0.675 (2.09%)

18:59
08/21/18
08/21
18:59
08/21/18
18:59
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

URBN

Urban Outfitters

$47.75

0.23 (0.48%)

LZB

La-Z-Boy

$33.03

0.675 (2.09%)

KEYS

Keysight Technologies

$60.47

0.28 (0.47%)

PSTG

Pure Storage

$22.03

0.23 (1.06%)

MYGN

Myriad Genetics

$42.83

0.9 (2.15%)

ZNGA

Zynga

$3.75

0.01 (0.27%)

STAR

iStar

$10.06

-0.04 (-0.40%)

FLEX

Flex

$13.80

0.17 (1.25%)

OCUL

Ocular Therapeutix

$6.12

0.07 (1.16%)

SMCI

Super Micro Computer

$18.45

-0.425 (-2.25%)

GSM

Ferroglobe

$8.11

0.09 (1.12%)

RRGB

Red Robin

$40.15

0.4 (1.01%)

NBEV

New Age Beverages

$1.59

0.05 (3.26%)

HA

Hawaiian Holdings

$43.70

-0.25 (-0.57%)

JILL

J.Jill

$6.85

-0.77 (-10.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 28

    Aug

  • 29

    Aug

  • 30

    Aug

  • 04

    Sep

  • 05

    Sep

  • 06

    Sep

  • 06

    Sep

  • 12

    Sep

  • 12

    Sep

  • 01

    Oct

  • 03

    Oct

  • 03

    Oct

  • 04

    Oct

  • 05

    Oct

  • 06

    Nov

  • 28

    Dec

  • 22

    Aug

TMUS

T-Mobile

$66.57

0.71 (1.08%)

, S

Sprint

$6.18

0.01 (0.16%)

18:43
08/21/18
08/21
18:43
08/21/18
18:43
Periodicals
T-Mobile asks smaller carriers to publicly support Sprint deal, Reuters says »

T-Mobile (TMUS) is asking…

TMUS

T-Mobile

$66.57

0.71 (1.08%)

S

Sprint

$6.18

0.01 (0.16%)

DTEGY

Deutsche Telekom

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

AOI

Alliance One

$18.10

0.25 (1.40%)

18:32
08/21/18
08/21
18:32
08/21/18
18:32
Hot Stocks
Alliance One approves names change to Pyxus Intl and changes board leadership »

Alliance One…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

HA

Hawaiian Holdings

$43.70

-0.25 (-0.57%)

18:01
08/21/18
08/21
18:01
08/21/18
18:01
Hot Stocks
Hawaiian Airlines to suspend Beijing service »

Hawaiian Airlines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

AL

Air Lease

$46.32

0.69 (1.51%)

18:01
08/21/18
08/21
18:01
08/21/18
18:01
Hot Stocks
Air Lease VP Marc Baer sells 10K shares of company stock »

Air Lease VP Marc Baer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 20

    Sep

CAAP

Corporacion America Airport

$8.82

-0.005 (-0.06%)

17:55
08/21/18
08/21
17:55
08/21/18
17:55
Hot Stocks
Corporacion America Airports reports Q2 passenger traffic up 7.4% »

Cargo volume increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

GLD

SPDR Gold Trust

$113.02

0.35 (0.31%)

17:33
08/21/18
08/21
17:33
08/21/18
17:33
Hot Stocks
SPDR Gold Trust SPDR Gold Trust holdings fall to 768.70MT from 772.24MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEB

Pebblebrook Hotel

$39.18

0.17 (0.44%)

, LHO

LaSalle Hotel

$34.45

-0.1 (-0.29%)

17:31
08/21/18
08/21
17:31
08/21/18
17:31
Hot Stocks
Pebblebrook Hotel increases terms of offer to merger with LaSalle Hotel »

Pebblebrook Hotel Trust…

PEB

Pebblebrook Hotel

$39.18

0.17 (0.44%)

LHO

LaSalle Hotel

$34.45

-0.1 (-0.29%)

BX

Blackstone

$36.49

-0.31 (-0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZNGA

Zynga

$3.75

0.01 (0.27%)

, DIS

Disney

$112.38

0.39 (0.35%)

17:30
08/21/18
08/21
17:30
08/21/18
17:30
Hot Stocks
Zynga reaches multi-year pact with Disney to developy mobile 'Star Wars' game »

Zynga (ZNGA) announced a…

ZNGA

Zynga

$3.75

0.01 (0.27%)

DIS

Disney

$112.38

0.39 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$286.28

0.6 (0.21%)

17:26
08/21/18
08/21
17:26
08/21/18
17:26
Periodicals
Cohen pleads guilty to campaign finance violations, other charges, AP says »

Former Trump lawyer…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$286.28

0.6 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KTOS

Kratos Defense

$13.14

0.18 (1.39%)

17:23
08/21/18
08/21
17:23
08/21/18
17:23
Hot Stocks
Kratos Defense awarded $109M U.S. Air Force contract »

Kratos Unmanned Aerial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Sep

LMT

Lockheed Martin

$324.20

0.06 (0.02%)

17:22
08/21/18
08/21
17:22
08/21/18
17:22
Hot Stocks
Lockheed Martin awarded $356.3M U.S. Army contract »

Lockheed Martin was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOLX

Hologic

$38.48

0.23 (0.60%)

17:21
08/21/18
08/21
17:21
08/21/18
17:21
Hot Stocks
Hologic commends USPSTF cancer screening recommendation »

Hologic commends the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 27

    Aug

  • 12

    Sep

STAR

iStar

$10.06

-0.04 (-0.40%)

, SHLM

A. Schulman

$44.00

(0.00%)

17:18
08/21/18
08/21
17:18
08/21/18
17:18
Hot Stocks
iStar to replace A. Schulman in S&P 600 at open on 8/27 »

S&P 500 constituent…

STAR

iStar

$10.06

-0.04 (-0.40%)

SHLM

A. Schulman

$44.00

(0.00%)

LYB

LyondellBasell

$114.94

0.95 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 11

    Sep

BTE

Baytex Energy

$2.98

0.125 (4.38%)

17:18
08/21/18
08/21
17:18
08/21/18
17:18
Hot Stocks
Baytex Energy and Raging River Exploration receive approvals for transaction »

Baytex Energy and Raging…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$286.28

0.6 (0.21%)

17:18
08/21/18
08/21
17:18
08/21/18
17:18
Periodicals
Breaking Periodicals news story on S&P 500, SPDR S&P 500 ETF Trust »

Former Trump lawyer…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$286.28

0.6 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAB

Wabtec

$110.40

0.2 (0.18%)

17:11
08/21/18
08/21
17:11
08/21/18
17:11
Hot Stocks
Wabtec's Brooks sells 20,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

ADI

Analog Devices

$95.95

2.23 (2.38%)

17:02
08/21/18
08/21
17:02
08/21/18
17:02
Hot Stocks
Analog Devices reinstates buyback, boosts authorization by $2B »

Analog Devices announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

SGBX

SG Blocks

$4.02

0.07 (1.77%)

17:02
08/21/18
08/21
17:02
08/21/18
17:02
Hot Stocks
Breaking Hot Stocks news story on SG Blocks »

Hillair Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFG

American Financial Group

$113.48

-0.315 (-0.28%)

17:01
08/21/18
08/21
17:01
08/21/18
17:01
Hot Stocks
American Financial Group raises dividend 14% to $1.60 »

American Financial Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

AGN

Allergan

$191.19

0.42 (0.22%)

17:01
08/21/18
08/21
17:01
08/21/18
17:01
Hot Stocks
Allergan receives CRL from FDA for ulipristal acetate NDA »

Allergan announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 12

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.